Innovent Biologics Unveils Promising Data on IBI3055 for Autoimmune Treatment at Summit 2026#China#Suzhou#Innovent_Biologics#IBI3055#T_Cell_Engager
Innovent Biologics Unveils Promising Data on IBI3055 for Autoimmune Treatment at Summit 2026
Innovent Biologics presents preclinical results of IBI3055, a tri-specific T cell engager aimed at treating autoimmune diseases, at the Immune Resetting Summit 2026.
third-news.com
April 10, 2026 at 12:10 AM
Innovent Biologics Unveils Promising Data on IBI3055 for Autoimmune Treatment at Summit 2026#China#Suzhou#Innovent_Biologics#IBI3055#T_Cell_Engager